Nemaura Medical Inc. (NMRD)

$0.03 -0.35% $-0.00 Healthcare

Nemaura Medical Inc., a medical technology company, discovers, develops, and commercializes diagnostic medical devices. It provides sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with Type I and Type II diabetes, as well as screen pre-diabetic patients. The company also offers proBEAT, a wellness guidance notes, that provide prompts and educate users on factors affecting blood sugar profiles, as well as conducts diabetes prevention and reversal programs. Nemaura Medical Inc. was founded in 2009 and is based in New York, New York.

$1.14M

Dr. Dewan Fazlul Hoque Chowdhury Ph.D.

32.00

New York, NY

Nov 04, 2014

-0.07

$-0.39

0.19

0.35

766.22%

-0.64

0.04

-0.50

-4.89

0.22

-133.87%

100.42%

Similar stocks (13)

Artivion, Inc.

AORT

$25.38 0.51%
Neutral

Orthofix Medical Inc.

OFIX

$16.53 -1.37%
Uptrend

Surmodics, Inc.

SRDX

$39.44 0.20%
Neutral

NeuroPace, Inc.

NPCE

$6.97 -6.19%
Downtrend

CVRx, Inc.

CVRX

$7.68 -2.17%
Downtrend

Electromed, Inc.

ELMD

$18.41 0.99%
Uptrend

Modular Medical, Inc.

MODD

$2.27 -2.58%
Uptrend

enVVeno Medical Corporation

NVNO

$5.44 1.12%
Neutral

Movano Inc.

MOVE

$0.34 3.04%
Downtrend

STRATA Skin Sciences, Inc.

SSKN

$3.02 -5.03%
Downtrend

Nexalin Technology, Inc.

NXL

$0.66 -2.41%
Downtrend

INVO Bioscience, Inc.

INVO

$0.70 -2.51%
Downtrend

Bluejay Diagnostics, Inc.

BJDX

$0.15 -0.79%
Downtrend